Tag Archive: Orphan Drug Designations

Mar 03 2010

Is there hope for Orphan Drug Designations in 2010?

Please, sir, may I have some more? – Oliver Twist 2009 was an interesting, if not to say harrowing, year for most drug and biologic companies.  Funding sources contracted, there were major cuts in R&D programs, and pipelines narrowed.  Everyone (and I really mean everyone – don’t let the big companies fool you) got creative …

Continue reading »

» Newer posts